Insurers won’t cover new Alzheimer’s treatment for some customers
Published
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.
Full ArticlePublished
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.
Full ArticleSome private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients...